Year Founded
2004
Ownership
Private
Employees
~5000
Therapeutic Areas
Stage
Other
Modalities
Aixial General Information
CRO conducting over 1580 studies across Phase I-IV, with trial sizes up to 33,189 patients across 610 sites globally
Drug Pipeline
No pipeline data available
Key Partnerships
ALTEN Group, Medidata
Aixial Funding
No funding data available
To view Aixial's complete valuation and funding history, request access »